Can a simple pill combo stop a second stroke?
NCT ID NCT06591377
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 29 times
Summary
This study compares two anti-clotting drug combinations—aspirin plus ticagrelor versus aspirin plus cilostazol—in 900 adults who recently had a minor stroke or transient ischemic attack (TIA) caused by a large blood vessel blockage. The goal is to see which combo better prevents new strokes and has fewer bleeding side effects over three months. Participants must start treatment within 24 hours of their first event and be between 18 and 75 years old.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
El-sahel teaching hospital
RECRUITINGCairo, 22514, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kafr Elsheikh University Hospital
RECRUITINGKafr ash Shaykh, 33511, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.